retatrutide trial sign up canada retatrutide trials Retatrutide Clinical Trial – My Endo Consult New Phase 3 retatrutide data

Side effects like nausea are typically related to the bodys initial adjustment to the peptide, especially its effect on slowing gastric emptying

Semaglutide works through an entirely different mechanism: it activates GLP-1 receptors in the pancreas, gut, and brain to slow stomach emptying, enhance insulin secretion, and reduce hunger signaling

Missing one application should not drastically affect results, but consistency is key

Avoid alcohol consumption during treatment to maximize liver benefits

The addition of GIP receptor activation was elegant in its simplicity and delivered tangible results

In preclinical studies, GIP and GLP1 reduce atherosclerosis